Fibromyalgia Syndrome Clinical Trial
Official title:
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome: A Randomised Controlled Trial
A Randomised Controlled Trial to evaluate the effectiveness of a Second-Generation Mindfulness-Based Intervention known as Meditation Awareness Training (MAT) for treating fibromyalgia syndrome.
Background: Fibromyalgia syndrome (FMS) is a chronic pain disorder that frequently leads to
poor quality of life. The need for more effective FMS treatments has prompted empirical
investigations into the applications of mindfulness for treating the condition. However,
studies have predominantly focused on first-generation mindfulness-based interventions
(FG-MBIs). To date, a randomised controlled trial (RCT) assessing the effectiveness of a
second-generation mindfulness-based intervention (SG-MBI) for treating FMS has not been
undertaken. SG-MBIs are distinct from FG-MBIs because they are overtly spiritual in nature
and employ (i) a greater range of (normally secularised) meditative/spiritual techniques,
(ii) ethics as a key component of the taught programme, and (iii) an instructor training
programme that typically requires several years of supervised mindfulness practice.
Aims: To evaluate the effectiveness of Meditation Awareness Training (MAT) - an SG-MBI - for
treating FMS.
Method: Adults with FMS will receive MAT or an active control intervention known as
Cognitive-Behavioural Therapy for Groups. Assessments will be performed at pre-intervention,
post-intervention, and follow-up phases.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05933486 -
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
|
Phase 4 | |
| Completed |
NCT01642810 -
Online Acceptance-based Behavioural Treatment for Fibromyalgia
|
Phase 3 | |
| Completed |
NCT00757731 -
FMS European Long-Term Study
|
Phase 3 | |
| Completed |
NCT00757679 -
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
|
Phase 2 | |
| Completed |
NCT01968772 -
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
|
N/A | |
| Completed |
NCT00401830 -
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
|
Phase 2 | |
| Completed |
NCT04517929 -
Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT06285045 -
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
|
N/A | |
| Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 | |
| Not yet recruiting |
NCT01465477 -
Influenza Vaccination in Fibromyalgia Patients
|
N/A | |
| Completed |
NCT00528710 -
Efficacy of S-Adenosylmethionine in Fibromyalgia
|
Phase 2 | |
| Completed |
NCT00447083 -
Benefits of Tanning in Fibromyalgia Patients
|
N/A | |
| Not yet recruiting |
NCT06147882 -
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
| Completed |
NCT00464737 -
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
|
Phase 2 | |
| Completed |
NCT04426864 -
Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.
|
N/A | |
| Completed |
NCT02881411 -
Self Soft Tissue Therapy for Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT01389336 -
Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone
|
N/A | |
| Not yet recruiting |
NCT01147263 -
Palpitations and Tachycardia in Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT00222274 -
HRV Biofeedback in Fibromyalgia
|
N/A |